#USA #Class Action #New Orleans #Kahn Swick #Cassava Sciences

Cassava Sciences Shareholder Alert

Kahn Swick & Foti, LLC (KSF), led by former Louisiana Attorney General Charles C. Foti, Jr., has issued a reminder to shareholders of Cassava Sciences, Inc. that they may be eligible to join a class action lawsuit. If you have experienced losses exceeding $100,000 due to fluctuations in the company’s stock, particularly between February 7, 2024, and November 24, 2024, your opportunity to act is imminent. The deadline for filing applications as lead plaintiffs is set for February 10, 2025.

This legal action is pending in the United States District Court for the Western District of Texas. Investors who acquired shares during the specified class period have the chance to discuss their rights and potential recovery options for financial losses with KSF. Those interested can contact Lewis Kahn, Managing Partner at KSF, toll-free or via email, to discuss available options without obligation or cost. For further details, interested parties can also explore the KSF website.

Background on the Lawsuit

The class action lawsuit alleges that Cassava Sciences and its executives failed to disclose significant material information during the class period, which constitutes a violation of federal securities laws. A turning point occurred on November 25, 2024, when the company revealed negative topline results from its Phase 3 clinical trials for its drug candidate simufilam. The results indicated that the drug failed to outperform a placebo across all defined primary, secondary, and exploratory endpoints.

In direct response to this startling news, Cassava's share price plummeted by approximately 83%, falling from $26.48 on November 22, 2024, down to just $4.30 by November 25, 2024. This dramatic decline has directly impacted shareholders, particularly those who had invested significant amounts during the Class Period.

How to Participate

To be involved in this lawsuit, shareholders need to file a petition to serve as lead plaintiffs by the deadline of February 10, 2025. This class action is officially registered as Crocker v. Cassava Sciences, Inc., et al., with the case number being No. 24-cv-1525.

Investors should take note that if you wish to lead this lawsuit, taking timely action is crucial, lest your opportunity to participate be lost.

About Kahn Swick & Foti, LLC

Kahn Swick & Foti, LLC stands as one of the leading boutique securities litigation firms in the United States. Their partner, Charles C. Foti, Jr., has a strong background in representing a diverse array of clients, including institutional investors, hedge funds, and retail investors. KSF is dedicated to recovering losses that stem from corporate fraud or other malfeasance perpetrated by publicly traded companies. In addition to its headquarters in Louisiana, KSF has established offices across several key states including New York, California, and Delaware.

For more information on this class action, potential plaintiffs, or the Kahn Swick & Foti law firm, you can visit their official website at www.ksfcounsel.com. This is an essential moment for investors affected by the recent fluctuations in Cassava’s stock to assess their legal options and determine their best path forward in seeking recovery for their economic losses.